Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aurinia Pharmaceuticals Inc - Common Shares (NQ:AUPH)

15.89 +0.01 (+0.06%)
Streaming Delayed Price Updated: 11:47 AM EST, Dec 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aurinia Pharmaceuticals Inc - Common Shares

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
Aurinia Pharma Stock Pops On Reports Of Looming Bristol Myers Takeover ↗
Bristol is reportedly interested in acquiring Aurinia, according to reports that sent AUPH stock flying before it was halted. 
Via Investor's Business Daily
News headline image
More Chinese Trouble ↗
A day after the consumer price rise there was another price rise for producer markets. 
Via Talk Markets
News headline image
A Bit Of A Recovery ↗
While Germany remains without a government, Japan has a new prime minister who will lead his party in the election this week. 
Via Talk Markets
News headline image
Pharma, Tech and Finance ↗
Good news on some drugs was not enough to boost stock markets. 
Via Talk Markets
Analyzing Aurinia Pharmaceuticals's Unusual Options Activity ↗
Aurinia Pharmaceuticals (NASDAQ:AUPH) shares experienced ... 
Via Benzinga
Analyzing Aurinia Pharmaceuticals's Unusual Options Activity ↗
Aurinia Pharmaceuticals (NASDAQ:AUPH) shares experienced ... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (... 
Via Benzinga
News headline image
Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
News headline image
Sunday Special ↗
I have a taste for nuclear electricity which France pioneered decades ago, building power stations along the Loire Valley and in other regions. So I took my taste for uranium into my US holdings. 
Via Talk Markets
Topics Energy
News headline image
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE... 
Via Benzinga
News headline image
Aurinia Pharmaceuticals to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Post-Rosh Hashanah, Sell? ↗
As the saying goes, sell Rosh Hashanah and buy Yom Kippur. Does it apply this year? 
Via Talk Markets
Aurinia Pharmaceuticals finalizes acquisition agreement with Leading Pharma Giant
Via Get News
News headline image
Aurinia Answers 'What's Next?' And Investors Punish AUPH Stock ↗
Aurinia snagged a pair of early-stage drugs for roughly $6.8 million on Tuesday, but AUPH stock tumbled into a key moving average. 
Via Investor's Business Daily
News headline image
Aurinia Adds Two Assets To Expand Its Immunology Pipeline ↗
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has added two assets to expand its rare autoimmune and kidney-related disease pipeline. The first program, AUR200, was... 
Via Benzinga
News headline image
Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune and Kidney-related Diseases
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotech Conference
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
84 Biggest Movers From Friday ↗
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 41.3% to close at $4.86 on Friday after the company inked an agreement with turnkey mining solutions provider Hertford... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Dow Gains 140 Points; Spectrum Pharmaceuticals Shares Plummet ↗
Toward the end of trading Friday, the Dow traded up 0.40% to 35,204.21 while the NASDAQ fell 0.41% to 14,833.72. The S&P also rose, gaining 0.16% to 4,435.97. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
Why Aurinia Pharmaceuticals Stock Was Surging on Friday ↗
Investors were relieved to see significant sales from the company's first commercial-stage drug. 
Via The Motley Fool
Topics Earnings
News headline image
Aurinia Pharmaceuticals Inc (AUPH) Q2 2021 Earnings Call Transcript ↗
AUPH earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Delta Outbreak ↗
The US market was droopy because of poor private sector jobless numbers. 
Via Talk Markets
News headline image
55 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares jumped 29.9% to $4.47 after the company inked an agreement with turnkey mining solutions provider Hertford Advisors Ltd to provide a... 
Via Benzinga
News headline image
Cramer Advises Viewers On Palantir, SoFi And More ↗
On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't understand why is MKS Instruments, Inc. (NASDAQ: MKSI) trading so cheap. He would be a buyer.... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
News headline image
88 Biggest Movers From Yesterday ↗
Gainers BeyondSpring Inc. (NASDAQ: BYSI) shares climbed 176% to close at $26.58 on Wednesday in reaction to topline data from DUBLIN-3 Phase 3 trial evaluating plinabulin in... 
Via Benzinga
News headline image
62 Biggest Movers From Yesterday ↗
Gainers Flora Growth Corp. (NASDAQ: FLGC) surged 63.1% to close at $8.27. The Miami-based cannabis producer confirmed Tuesday it has signed a non-binding letter of intent to... 
Via Benzinga
Topics Cannabis
News headline image
Understanding Aurinia Pharmaceuticals's Unusual Options Activity ↗
On Wednesday, shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) saw unusual options activity. After the option alert, the stock price moved up to $12.55. Sentiment: BULLISH Option... 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.